VIRASHIELD Organic Herbal Nano Nasal Sprays DAY & NIGHT TWO PACK

  • Sale
  • Regular price $80.00
  • Will be in stock after


Healthy Pathways & Ascent Labs have partnered to develop

Organic Herbal Nano ViraShield Nasal Sprays to

treat and block a broad spectrum of respiratory viruses including SARS-CoV-2

Each organic herb has been used chosen for its excellent safety profile and

research proven efficacy against a broad range of respiratory viruses including SARS-CoV-2 (Covid).

 

"We use a proprietary nanotechnology during production that supercharges the efficacy of Virashield. This allows every milliliter of spray to be densely packed with the potent active components from the traditional herbs used, while also rapidly accelerating the rate of transport for these medicinal compounds across the membranes lining the nasal cavity and respiratory pathways. Best of all, this technology is completely safe as it is built by structurally modifying simple, natural sugar molecules."

 

We sell both a DAY and a NIGHT version of our nano nasal spray

DAY SPRAY: Organic Ingredients: Honeysuckle Flower, Aloe & Andrographis

NIGHT SPRAY: Organic Ingredients: Honeysuckle Flower, Aloe, Andrographis & Melatonin*

*(Melatonin is NOT for use while driving or operating heavy machinery)

 

Directions for use: We suggest patients use our organic herbal nano nasal sprays upon exposure or infected with a virus, pathogen or allergen three to four times per day. 

Please do not use when pregnant or nursing. Do not use the night nasal spray with melatonin while driving or operating machinery.

 Do not use if allergic to any of the ingredients.

 

·       All above ingredients are research proven effective broad spectrum anti-virals.

·       We have also found our nasal sprays show efficacy for seasonal allergies, sinusitis and                        loss of smell and taste with Covid.

Relevant Research -

·        https://scitechdaily.com/melatonin-produced-in-the-lungs-prevents-covid-19-infection/

·        https://www.nature.com/articles/s41421-020-00197-3

·        https://www.biorxiv.org/content/10.1101/2020.12.08.415836v1